Saliva Collection and Diagnostics Market Industry Growth, Competitors Analysis, New Technology, Trends and Forecast 2021 - 2028
The budding demand for quick diagnosis of life-threatening
diseases has increased product approvals for saliva collecting and diagnostic
devices. As per MRFR, the market is estimated to gain a CAGR of 11.17% and
achieve revenues worth USD 5,470.08 Million by 2027.
The requirement for Saliva
Collection and Diagnostics Market is skyrocketing, owing to an increase
in the number of disorders requiring saliva samples' testing. The saliva
collection devices market, on the other hand, is severely hampered by the large
debts of setting up the equipment required to conduct quality and ethical
saliva collection. The global market is primarily driven by widespread
improvements in healthcare and medicine, particularly in the testing and
development of new medical procedures, medications, and experiments.
Get Sample Reports- https://www.marketresearchfuture.com/sample_request/2522
Major key players
Many key players present in the market contribute to the
Saliva Collection and Diagnostics Market in different ways. Here are some of
the prominent key players who have the highest contribution to the market's
growth.
Neogen Corporation. (US), OraSure Technologies (US), Abbott
Laboratories (US), SARSTEDT AG and Co. KG (Germany), Quest Diagnostics (US),others.
Segmental Analysis
The saliva collecting and diagnostic devices market
segmentation is conducted based on the site of collection, region, application,
and end user. The saliva collection and diagnostic market have been segmented
into submandibular/sublingual gland collection, minor salivary glands collection,
and parotid gland collection based on the collection site.
·
The end user segment has been segregated
into hospitals, dental clinics, investigation laboratories, and diagnostic
centres.
·
Segmented by application Disease
diagnosis, pharmaceutical, and biotechnology firms, and forensics.
·
By region, the saliva collection and
diagnostic market are segmented into Europe, Asia-Pacific, the Americas, and
the Middle East & Africa.
Detailed Regional Analysis
The regional assessment of the saliva collection and
diagnostic market is segmented into Europe, Asia-Pacific, the Americas, and the
Middle East & Africa. During the forecast era, the Americas led the market
and is set to continue to do so during the evaluation period. This is due to
developments in illness testing technology and an increase in the prevalence of
chronic diseases. Due to various favorable government initiatives, a wide
target population base, and an increased cancer rate, Europe would trail the
Americas in terms of value during the predicted period. Escalating per capita
health spending, the development of the healthcare sector in China, India, and
Australia, burgeoning demand for saliva collection and diagnostic tools for
respiratory procedures, and an aging population suffering from various
diseases, Asia-Pacific is reported to witness the highest growth potential
during the forecast period.
Competitive Analysis
After the decline seen in the aftermath of the pandemic, the
government bodies of various nations are believed to play an important role in
the worldwide market's resuscitation. The minimization of supply chain
bottlenecks is the main objective that market challengers are intended to
address aggressively in the predicted year. During the forecast period, the
market is anticipated to offer new and profitable expansion options. The battle
for the majority share is predicted to change the market landscape in the
forecast period fundamentally. The market is more inclined to conduct business
transactions online than in physical locations. End-users in the business are
predicted to exhibit a wide range of preferences in the coming years. Companies
now have a new mission surrounding the customer journey and the rapid
acceleration of digitalization due to the global pandemic. However, the
upheaval produced by the COVID crisis has not only created a whole new
dimension of risk. Still, it has also prompted enterprises to reassess risks as
they navigate cautiously through an uncertain economic climate.
Industry Updates:
·
July 2021 Psomagen, Inc., a
CLIA-certified genetic analysis service provider, expands its SARS-CoV-2
diagnostic services to meet the public's changing COVID-19 testing demands. The
company now offers direct-to-consumer saliva collection kits for diagnosing
COVID-19 for individuals 18 and older, in addition to its GutBiome and Gene
Trait testing.
Browse Full Reports- https://www.marketresearchfuture.com/reports/saliva-collection-devices-diagnostics-market-2522
Related Reports: Hyperhidrosis
Treatment Market Research Report - Global Forecast till 2027
Global
Healthcare Data Storage Market Research Report—Forecast till 2027
Market Research
Future (MRFR) enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment